- Biotechnology and Nanomedicine
- Clinical Neuroscience
- Cognitive and Behavioural Neuroscience
- Computational and Systems Neuroscience
- Molecular and Cellular Neuroscience
- Neuroimaging and Methodological research
Seminar on “European Brain Council: activities and opportunities”
On April 14th, 2016 at 10 a.m in the building U8 – room 1 at the University of Milano-Bicocca in Monza…
Clinical Neuroscience and Behaviour: Prof. Cavanna, March 16th 2016
Clinical Neuroscience and Behaviour Prof. Andrea Eugenio Cavanna, MD PhD FRCP Consultant in Behavioural Neurology, BSMHFT, Birmingham, UK Hon. Professor in…
cyTRON project in Google Summer of Code
BIMIB has entered as a “mentor group” in the latest Google Summer of Code under the auspices of the National Resource…
New NeuroMI paper on ALS: MEF2 pathways disruption
Amyotrophic lateral sclerosis (ALS) is a progressive neuro-muscular disease characterized by motor neuron loss. MEF2D and MEF2C are members of the…
Seminar on “Clinical Neuroscience and behaviour”
On March 16th, 2016 at noon in the building U8–room 8 at the University of Milano-Bicocca in Monza (Via Cadore, 48) Prof….
New publication on ALS genetics leaded by the ITALSGEN consortium: ATXN2 & C9ORF72
A new paper of the ITALSGEN and SARDINIALS consortia listing some NeuroMI members among participants. Neurobiol Aging. 2015 Dec 8. pii:…
New publication on amyotrophic lateral sclerosis
Neurodegener Dis. 2016 Jan 9. [Epub ahead of print] BDNF Serum Levels with Respect to Multidimensional Assessment in Amyotrophic Lateral Sclerosis….
Visual disturbances in patients with cerebrovascular lesion – Monza, Nov 28th, 2015
Visual disturbances in patients with cerebrovascular lesion: assesssment and rehabilitation Nov 28th, 2015; h. 09.00-17.00 San Gerardo Hospital – Monza; Conference…
- Biotechnology and Nanomedicine
- Clinical Neuroscience
- Cognitive and Behavioural Neuroscience
- Computational and Systems Neuroscience
- Molecular and Cellular Neuroscience
- Neuroimaging and Methodological research
- Uncategorized
NeuroMI has been accepted to be part of the Centres of Excellence within the European Alzheimer’s Disease Consortium (EADC).
I’m glad to announce that the 4th of November, during the EADC General Assembly held in Barcelona, the NeuroMI has been…